FDA Inspection 1067678 — Qilu Antibiotics Pharmaceutical Co. , Ltd.
The FDA completed an inspection of Qilu Antibiotics Pharmaceutical Co. , Ltd. on August 16, 2018 in Jinan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)